Vaccitech to Host Virtual KOL Event on VTP-300, a Potential Functional Cure for Chronic Hepatitis B (CHB) Infection, and the Broader CHB Therapeutics Landscape

NEXT STORY
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Talis Biomedical Corporation (TLIS) Investors
PREV STORY
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

argenx awarded €2.5 million VLAIO grant to identify novel therapeutic antibodies

Grant to fund research of novel targets involved in regulation of locally-released TGF-beta, a ...

author_avatar
NASDAQ Market News

Alliqua BioMedical, Inc. and BSN medical, Inc. Announce Definitive Agreement on Distribution Rights for Sorbion Dressing Products in the U.S., Canada and Latin America; Alliqua Updates Fiscal Year 2016 Outlook

YARDLEY, Pa. and CHARLOTTE, N.C., July 07, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. ...

author_avatar
NASDAQ Market News

G1 Therapeutics Announces Acceptance and Priority Review of NDA for Trilaciclib for Patients with Small Cell Lung Cancer

author_avatar
NASDAQ Market News